SMS Pharmaceuticals has informed that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st January, 2022 till 48 hours after the declaration of unaudited financial results for the 3rd quarter ended as on 31st December, 2021, in terms of the Code of Conduct of the Company.
The above information is a part of company’s filings submitted to BSE.